Abstract
Background: Despite contraception being specified for men and women of child-bearing potential in clinical trials of cladribine in patients with MS, pregnancies occurred. Objective: Report pregnancy outcomes from an integrated analysis of safety for patients with MS exposed to cladribine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.